These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 2360238

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Purified factor IX using monoclonal immunoaffinity technique: clinical trials in hemophilia B and comparison to prothrombin complex concentrates.
    Kim HC, McMillan CW, White GC, Bergman GE, Horton MW, Saidi P.
    Blood; 1992 Feb 01; 79(3):568-75. PubMed ID: 1531035
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Products for the treatment of hemophilia A and B prepared by ion exchange chromatography.
    Sultan Y, Boyeldieu D, Stieltjes N.
    Nouv Rev Fr Hematol (1978); 1994 Feb 01; 36 Suppl 1():S59-60. PubMed ID: 8177717
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul 15; 153(2):147-57. PubMed ID: 7600466
    [Abstract] [Full Text] [Related]

  • 10. Perioperative Management of Mild Hemophilia B During and After Coronary Artery Bypass Grafting: Challenges and Solutions.
    Fernando RJ, Farmer BE, Augoustides JG, Gardner JC, Johnson SD, Ha B, Friess JO, Luedi MM, Erdoes G, Miller PJ, Ripat C, Fabbro M.
    J Cardiothorac Vasc Anesth; 2019 Feb 15; 33(2):549-555. PubMed ID: 30177475
    [No Abstract] [Full Text] [Related]

  • 11. Optimizing the treatment of haemophilia B: laboratory and clinical perspectives.
    Aledort LM.
    Haemophilia; 2010 Jul 15; 16 Suppl 6():1-2. PubMed ID: 20561350
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Markers of hypercoagulability in patients with hemophilia B given repeated, large doses of factor IX concentrates during and after surgery.
    Santagostino E, Mannucci PM, Gringeri A, Tagariello G, Baudo F, Bauer KA, Rosenberg RD.
    Thromb Haemost; 1994 Jun 15; 71(6):737-40. PubMed ID: 7974341
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Reduced bleeding events with subcutaneous administration of recombinant human factor IX in immune-tolerant hemophilia B dogs.
    Russell KE, Olsen EH, Raymer RA, Merricks EP, Bellinger DA, Read MS, Rup BJ, Keith JC, McCarthy KP, Schaub RG, Nichols TC.
    Blood; 2003 Dec 15; 102(13):4393-8. PubMed ID: 12933577
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Adherence to clotting factors among persons with hemophilia A or B.
    Armstrong EP, Malone DC, Krishnan S, Wessler MJ.
    Hematology; 2015 Apr 15; 20(3):148-53. PubMed ID: 25001343
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long-Term Safety and Efficacy of Recombinant Coagulation Factor IX Albumin Fusion Protein (rIX-FP) in Previously Treated Pediatric Patients with Hemophilia B: Results from a Phase 3b Extension Study.
    Kenet G, Chambost H, Male C, Halimeh S, Lambert T, Li Y, Seifert W, Santagostino E.
    Thromb Haemost; 2020 Apr 15; 120(4):599-606. PubMed ID: 32185782
    [Abstract] [Full Text] [Related]

  • 20. [Prophylaxis in haemophilia B. Prevention of bleeds and FIX consumption].
    Siegmund B, Richter H, Pollmann H.
    Hamostaseologie; 2010 Nov 15; 30 Suppl 1():S35-8. PubMed ID: 21042666
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.